| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:CPI703
CAS:1904649-00-8
Package:1removed
|
CPI703 manufacturers
- CPI703
-
- $2500.00 / 100mg
-
2026-04-21
- CAS:1904649-00-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| Product Name: | CPI703 | | Synonyms: | CPI703;2H-1,5-Benzodiazepin-2-one, 6-[1-(1,1-dimethylethyl)-1H-pyrazol-4-yl]-1,3,4,5-tetrahydro-4-methyl-, (4R)- | | CAS: | 1904649-00-8 | | MF: | C17H22N4O | | MW: | 298.38 | | EINECS: | | | Product Categories: | | | Mol File: | 1904649-00-8.mol |  |
| | CPI703 Chemical Properties |
| Boiling point | 513.7±50.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | pka | 14.61±0.40(Predicted) |
| | CPI703 Usage And Synthesis |
| Uses | CPI703, a BRD inhibitor, binds with residues in domain1 of 5DBM complex[1]. | | References | [1] Srimoyee Ghosh, et al. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition. J Biol Chem. 2016 Jun 17;291(25):13014-27. DOI:10.1074/jbc.M115.708560
[2] Xue-Song Wang, et al. Theoretical research in structure characteristics of different inhibitors and differences of binding modes with CBP bromodomain. Bioorg Med Chem. 2018 Feb 1;26(3):712-720. DOI:10.1016/j.bmc.2017.12.040 |
| | CPI703 Preparation Products And Raw materials |
|